English | Español
English | Español
  • Insurance
  • Marketing
  • Pharmaceuticals
  • Technology/Innovation
  • Regulatory
  • Community
Patient Daily | May 4, 2023

Xoran Technologies® Announces New Independent Director

Patient Daily | May 4, 2023

Completion of Enrollment in Cohorts C and G of China Phase II Clinical Study of Osemitamab (TST001) in Combination with CAPOX with or without Nivolumab as First-line Treatment of Gastric/Gastro-esophageal Junction Cancer Patients

Patient Daily | May 4, 2023

Accelerate Diagnostics scheduled call to review 2023 first quarter results

Patient Daily | May 4, 2023

Accelerate Diagnostics Reports Fourth Quarter and Full Year 2022 Financial Results

Patient Daily | May 4, 2023

Exagen Announces Campaign for Lupus Awareness Month

Mifeed | May 4, 2023

LeanTaaS Earns Highest Ratings in Inaugural KLAS Capacity Optimization Management Report

Patient Daily | May 4, 2023

Twist and Shout: Helix is Weaving Population Genomics into the Healthcare Fabric

Sam Jackson | May 1, 2023

World's first customizable vascular biometric monitor receives FDA 510(k) clearance

Trending

Patient Daily | Sep 3, 2025

Top healthcare marketing experts to present at AOCOO-HNS 2025 virtual mid-year symposium, led by Greg Caesar of Medfluence Advisors

+ Pharmaceuticals
Patient Daily | Sep 4, 2025

PhRMA CEO on 340B abuse: ‘Big hospitals are abusing the 340B program to markup medicine prices’

+ Pharmaceuticals
Patient Daily | Sep 2, 2025

Fmr. Gov. Dean on 340B: ‘There's no actual requirement for hospitals to pass along the savings’

+ Pharmaceuticals
Patient Daily | Aug 29, 2025

Deputy VP of Public Affairs of PhRMA on 340B: ‘Over 80% of all rural hospital beds were actually in urban hospitals’

  • « First
  • «
  • …
  • 66
  • 67
  • 68
  • 69
  • 70
  • 71
  • 72
  • …
  • »
  • Last »


Community
Insurance
Marketing
Pharmaceuticals
Regulatory
Technology/Innovation
About
Contact
© 2025 Patient Daily